Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use
Alert update May 2023: Periprocedural diabetic ketoacidosis (DKA) with sodium-glucose co-transporter-2 inhibitor use in people with diabetes.
ANZCA Regional and Rural Workforce Strategy
Regional and rural workforce strategy
CPD-Medical-masters-a-pilot-study-of-adaptive-ageing-in-physicians
PG58(A)BP Guideline on quality assurance and quality improvement in anaesthesia Background Paper
PG58(A)BP Guideline on quality assurance and quality improvement in anaesthesia Background Paper
Capital Pain and Rehabilitation Clinic 20191213
RI template advanced training
PG43(A) Guideline on fatigue risk management in anaesthesia practice
PG43(A) Guideline on fatigue risk management in anaesthesia practice
PS26(A) Position statement on informed consent for anaesthesia or sedation
PS26(A) Position statement on informed consent for anaesthesia or sedation
PG63(A)BP Guideline for safe care for patients sedated in health care facilities for ABD BP
PG63(A)BP Guideline for safe care for patients sedated in health care facilities for acute behavioural disturbance Background Paper
CP24(G) Policy for the development and review of professional documents
CP24(G) Policy for the development and review of professional documents